Pancreatic Diseases Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Pancreatic Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

Pancreatic CancerPancreatitisPancreatic Cyst+1 more
Memorial Sloan Kettering Cancer Center700 enrolled13 locationsNCT03334708
Recruiting

UCSF PANC Cyst Registry

Pancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Neoplasms+5 more
University of California, San Francisco4,000 enrolled1 locationNCT04291651
Recruiting

Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study

Pancreatic DiseasesPancreatic Cancers
Do Hyun Park263 enrolled3 locationsNCT07030348
Recruiting

Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations

Pancreatic Ductal AdenocarcinomaPancreatic Neuroendocrine TumorPancreatic Neoplasms+3 more
Qilu Hospital of Shandong University2,100 enrolled1 locationNCT06041009
Recruiting

OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.

NeoplasmsNeoplasms by SitePancreatic Neoplasm+5 more
OncoSil Medical Limited500 enrolled9 locationsNCT04493632
Recruiting

PAncreatic Disease Cohort of TOuLouse

Pancreatic Diseases
University Hospital, Toulouse300 enrolled1 locationNCT05824403
Recruiting

Improving Pancreatic Cancer Care by the Use of Computational Science and Technology

Pancreatic CancerPancreatic AdenocarcinomaPancreas Adenocarcinoma+3 more
UMC Utrecht5,000 enrolled1 locationNCT06055010
Recruiting

Registry of Pancreatic Disease

Pancreatic NeoplasmsPancreatitisPancreatic Diseases
Azienda Ospedaliera Universitaria Integrata Verona3,000 enrolled1 locationNCT03807687